BioSpace News Archive

Business

Orexo Q2 2021 Interim Report

First patient enrolled in pivotal study evaluating the efficacy of modia™ in combination with sublingual buprenorphine/naloxone for the treatment of opioid use disorder.

July 15, 2021
·
3 min read
Business

Vitrolife AB (publ) - Interim report January - June 2021: Good growth and acquisition of Igenomix

Sales amounted to SEK 382 (209) million, corresponding to an increase of 83 percent in SEK. Sales increased by 94 percent in local currency.

July 15, 2021
·
2 min read
Business

Biofidelity Announces Formation of Scientific Advisory Board

Biofidelity Ltd, the cancer diagnostics company, announces the members of its newly-formed Scientific Advisory Board with the appointments of leaders from the clinical, pharmaceutical and patient advocacy fields.

July 15, 2021
·
2 min read
Genetown

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation

PAQ Therapeutics, a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, announced the completion of its $30 million Series A financing.

July 15, 2021
·
4 min read
Business

Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately.

July 15, 2021
·
2 min read
Drug Development

Synlogic Announces Initiation of Phase 1 Study of SYNB1934, a Next-Generation Strain for the Treatment of Phenylketonuria (PKU)

Synlogic, Inc., a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced that it has initiated the Phase 1 clinical trial of SYNB1934, an investigational Synthetic Biotic™ medicine for the treatment of Phenylketonuria.

July 15, 2021
·
5 min read
Business

Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021

Amarin Corporation plc announced that it will host a conference call with members of Amarin senior management to discuss the company’s second quarter and six month 2021 financial results and provide an operational update on Thursday, August 5, 2021, at 7:30 a.m. ET.

July 15, 2021
·
2 min read
U.S. Injectable Compounding Pharmacy Market | Exclusive Report on the Latest Trends and Developments in the Market

The U.S. injectable compounding pharmacy market is prognosticated to observe profitable growth during the forecast period of 2020-2030.

July 15, 2021
·
3 min read
Proctoscopes Market: Trunk-end proctoscopes segment accounted for the largest market share

Colorectal specialists perform examination of the rectum with the help of a specialized diagnostic device called proctoscope.

July 15, 2021
·
5 min read
Medical Equipment Calibration Services Market Survey | Expansive Coverage on the Novel Profit-Yielding Sources

Pieces of biomedical equipment need to be calibrated according to the prevailing industry regulations pertaining to patient’s safety and efficacy of the devices.

July 15, 2021
·
3 min read